Why Supplement Contamination Causes Positive Tests

A substantial share of anti-doping cases involve an athlete who took a product sold openly and legally. The route from a shop shelf to an adverse finding runs through manufacturing rather than intent.

Shared equipment carries residue between products

Many supplement companies do not own factories. Production is contracted out, and a single line may run a sports product, a weight-loss formula and a hormone-adjacent product in sequence.

Cleaning between runs reduces residue but does not eliminate it at the concentrations modern testing detects. Laboratories can identify quantities far below any pharmacological effect.

That gap between detectable and effective is the core of the problem. An athlete can fail a test on a quantity that did nothing at all for performance.

Ingredient sourcing adds a second failure point

Raw ingredients pass through brokers and are frequently imported, so the finished-product brand may not know the full chain behind a single component.

Botanical extracts are particularly variable, since plant material differs by origin and season and can contain compounds that are prohibited in sport.

Some contamination is deliberate. A product that produces no noticeable effect sells poorly, which creates an incentive to add an active compound that is not declared.

Labels are not a reliable control

Regulation of supplements in most jurisdictions is lighter than for medicines, and pre-market approval of the specific formulation is often not required.

Ingredient names on labels can be chemical synonyms, trade names or plant names, so a prohibited substance may be listed under a term an athlete would not recognise.

Proprietary blends compound this by declaring a total quantity for a group of ingredients without stating individual amounts.

Strict liability places the risk on the athlete

Anti-doping rules hold the athlete responsible for what is in a sample regardless of how it arrived. Contamination affects the sanction, not the finding itself.

To reduce a ban, an athlete must identify the source, which usually means producing a sealed sample of the same batch and having it analysed.

That evidential burden is why athletes are advised to keep the container and the batch number of anything consumed, sometimes for years.

Risk reduction is about sourcing, not avoidance

Complete avoidance is rarely practical, since some products address documented deficiencies identified by a clinician.

The main control is choosing products from third-party batch-testing programmes, which analyse samples from specific production runs and publish the result against a batch number.

Batch testing lowers the probability of contamination rather than removing it, and athletes are told plainly that no programme can offer a guarantee.